Elisabeth Sthengel
Directeur Technique/Scientifique/R&D chez INVENT MEDIC SWEDEN AB
Postes actifs de Elisabeth Sthengel
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| INVENT MEDIC SWEDEN AB | Directeur Technique/Scientifique/R&D | 01/06/2017 | - |
Historique de carrière de Elisabeth Sthengel
Anciens postes connus de Elisabeth Sthengel
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
NOLabs AB
 NOLabs AB Medical SpecialtiesHealth Technology NOLabs AB is a holding company that explores and develops proprietary therapies for diabetic patients where current treatment options are insufficient or complicated. It is a medical device company that focuses on its core technology, as well as the development of therapeutic applications for diabetic pain relief. Its product contains NitroSense Nitric Oxide (NO) delivery system and is a multilayer patch that is designed to release NO in a controlled manner. The firm core concept of NitroSense Technology is combining a substance and a delivery system to create h products for local delivery of NO. The company was founded in 2004 and is headquartered in Helsingborg, Sweden. | Corporate Officer/Principal | 05/02/2010 | - |
Statistiques
Internationale
| Suède | 3 |
Opérationnelle
| Corporate Officer/Principal | 1 |
| Chief Tech/Sci/R&D Officer | 1 |
Sectorielle
| Health Technology | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| INVENT MEDIC SWEDEN AB | Health Technology |
| Entreprise privées | 1 |
|---|---|
NOLabs AB
NOLabs AB Medical SpecialtiesHealth Technology NOLabs AB is a holding company that explores and develops proprietary therapies for diabetic patients where current treatment options are insufficient or complicated. It is a medical device company that focuses on its core technology, as well as the development of therapeutic applications for diabetic pain relief. Its product contains NitroSense Nitric Oxide (NO) delivery system and is a multilayer patch that is designed to release NO in a controlled manner. The firm core concept of NitroSense Technology is combining a substance and a delivery system to create h products for local delivery of NO. The company was founded in 2004 and is headquartered in Helsingborg, Sweden. | Health Technology |
- Bourse
- Insiders
- Elisabeth Sthengel
- Expérience